New Weight Loss Treatment: Mounjaro (Tirzepatide) Rollout
Important Notice: We are still awaiting prescribing guidelines for Mounjaro in Primary Care from NHS England.
If you submit an eConsult and meet the eligibility criteria, you will be added to our waiting list. We will contact you as soon as guidance is finalized for North-West London.
North west London is participating in the national rollout of Tirzepatide (Mounjaro®)—a new treatment being introduced in the NHS across England to support people living with obesity and serious related health conditions.
Please note that this medication is only available to patients who meet strict clinical eligibility criteria. To clarify, the NHS has very strict guidance about who is eligible to receive this weight loss drug. The following criteria applies:
People must have:
- a BMI of 40 or over (37.5 if from an ethnic background); Calculate your body mass index (BMI) for adults – NHS
- and 4 out of 5 of the following conditions: type 2 diabetes, high blood pressure, heart and vascular disease, high cholesterol and obstructive sleep apnoea.
Unfortunately if you do not fulfil all of the above criteria we will not be able to prescribe this medication for you.
Important:
- Requests for Mounjaro will only be considered if submitted with the screenshot of your BMI attached via our eConsult system, accessible on our website. Calculate your body mass index (BMI) for adults – NHS and if it meets the criteria above attach it to the eConsult.
- Do not phone or visit the surgery to request this treatment — our reception team is unable to process or assess eligibility.
- Before submitting a request, please review the eligibility criteria for weight management treatments on the NHS.
Mounjaro is part of a wider national rollout and supplies are currently limited. We appreciate your understanding as we assess requests carefully and prioritise patients based on clinical need.
To submit a request, please use the eConsult service.
For more information and FAQs about the rollout click: Tirzepatide :: North West London ICS
For safety information, including side effects click: Tirzepatide | Drugs | BNF | NICE
If you’re not in the first group to be eligible as part of the phased national roll out, there are still many ways to access weight management help. You can speak to your GP about a referral to a local Tier 3 weight management service, or ask about the NHS Digital Weight Management Programme, which is widely available across the NHS. These services can support your health now and may also help prepare for future access to new treatments.
Thank you for your cooperation.